Back to Search
Start Over
108MO Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6)
- Source :
- Annals of Oncology. 33:S81-S82
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Oncology
Hematology
Subjects
Details
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........28e7ba842f4431dc27ea0059c9afd78e
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.02.135